[{"NetIncomeLossConverted_1_Q1_USD":178372000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":144900000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":143999000.0,"EarningsPerShareDiluted_1_Q1_USD":1.22,"CommonStockSharesOutstanding_0_Q1_shares":144908192.0,"StockholdersEquity_0_Q1_USD":2678860000.0,"RevenuesConverted_1_Q1_USD":751944000.0,"Assets_0_Q1_USD":4620844000.0,"CommonStockSharesConverted_0_Q1_shares":186744426.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.39,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":146100000.0,"EarningsPerShareBasic_1_Q1_USD":1.23,"Ticker":"RMD","CIK":"943819","name":"RESMED INC","OfficialName":"ResMed Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"35011402698.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"SP500","filed":"20201030"}]